Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.

Bernstein JA, Manning ME, Li H, White MV, Baker J, Lumry WR, Davis-Lorton MA, Jacobson KW, Gower RG, Broom C, Fitts D, Schranz J.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):77-84. doi: 10.1016/j.jaip.2013.09.008. Epub 2013 Nov 11.

PMID:
24565773
[PubMed - indexed for MEDLINE]
2.

Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.

Lyseng-Williamson KA.

BioDrugs. 2011 Oct 1;25(5):317-27. doi: 10.2165/11208390-000000000-00000. Review.

PMID:
21942916
[PubMed - indexed for MEDLINE]
3.

Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.

Zuraw BL, Kalfus I.

Am J Med. 2012 Sep;125(9):938.e1-7. doi: 10.1016/j.amjmed.2012.02.020. Epub 2012 Jul 14.

PMID:
22800873
[PubMed - indexed for MEDLINE]
4.

Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.

Gandhi PK, Gentry WM, Bottorff MB.

Pharmacotherapy. 2012 Oct;32(10):902-9. doi: 10.1002/j.1875-9114.2012.01126.

PMID:
23033229
[PubMed - indexed for MEDLINE]
5.

Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.

Grant JA, White MV, Li HH, Fitts D, Kalfus IN, Uknis ME, Lumry WR.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):348-53. doi: 10.2500/aap.2012.33.3585.

PMID:
22856635
[PubMed - indexed for MEDLINE]
6.

Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.

Riedl MA, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I.

Ann Allergy Asthma Immunol. 2012 Jan;108(1):49-53. doi: 10.1016/j.anai.2011.10.017. Epub 2011 Nov 21.

PMID:
22192966
[PubMed - indexed for MEDLINE]
7.

Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.

Lumry W, Manning ME, Hurewitz DS, Davis-Lorton M, Fitts D, Kalfus IN, Uknis ME.

J Pediatr. 2013 May;162(5):1017-22.e1-2. doi: 10.1016/j.jpeds.2012.11.030. Epub 2013 Jan 11.

PMID:
23312695
[PubMed - indexed for MEDLINE]
8.

Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.

Riedl MA, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME.

Am J Rhinol Allergy. 2013 Nov-Dec;27(6):517-21. doi: 10.2500/ajra.2013.27.3973.

PMID:
24274230
[PubMed - indexed for MEDLINE]
9.

Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.

Baker JW, Craig TJ, Riedl MA, Banerji A, Fitts D, Kalfus IN, Uknis ME.

Allergy Asthma Proc. 2013 Mar-Apr;34(2):162-9. doi: 10.2500/aap.2013.34.3645.

PMID:
23484892
[PubMed - indexed for MEDLINE]
10.

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.

Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, Triggiani M, Montinaro V, Cillari E, Realdi G, Cancian M, Visscher S, Zanichelli A, Relan A, Cicardi M.

Clin Exp Allergy. 2012 Jun;42(6):929-35. doi: 10.1111/j.1365-2222.2012.03984.x.

PMID:
22909164
[PubMed - indexed for MEDLINE]
11.

Cinryze (C1-inhibitor) for the treatment of hereditary angioedema.

Gompels MM, Lock RJ.

Expert Rev Clin Immunol. 2011 Sep;7(5):569-73. doi: 10.1586/eci.11.50. Review.

PMID:
21895469
[PubMed - indexed for MEDLINE]
12.

Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.

Gower RG, Lumry WR, Davis-Lorton MA, Johnston DT, Busse PJ.

Allergy Asthma Proc. 2012 May-Jun;33(3):235-40. doi: 10.2500/aap.2012.33.3573. Review.

PMID:
22584192
[PubMed - indexed for MEDLINE]
13.

Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.

Craig TJ, Bewtra AK, Hurewitz D, Levy R, Janss G, Jacobson KW, Packer F, Bernstein JA, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):354-61. doi: 10.2500/aap.2012.33.3589.

PMID:
22856636
[PubMed - indexed for MEDLINE]
14.

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.

Craig TJ, Bewtra AK, Bahna SL, Hurewitz D, Schneider LC, Levy RJ, Moy JN, Offenberger J, Jacobson KW, Yang WH, Eidelman F, Janss G, Packer FR, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy. 2011 Dec;66(12):1604-11. doi: 10.1111/j.1398-9995.2011.02702.x. Epub 2011 Sep 2.

PMID:
21884533
[PubMed - indexed for MEDLINE]
15.

When is prophylaxis for hereditary angioedema necessary?

Craig T, Riedl M, Dykewicz MS, Gower RG, Baker J, Edelman FJ, Hurewitz D, Jacobs J, Kalfus I.

Ann Allergy Asthma Immunol. 2009 May;102(5):366-72. doi: 10.1016/S1081-1206(10)60506-6. Review.

PMID:
19492656
[PubMed - indexed for MEDLINE]
17.

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtułowicz K, Reshef A, Ritchie B, Moldovan D, Shirov T, Grivcheva-Panovska V, Kiessling PC, Keinecke HO, Bernstein JA.

J Allergy Clin Immunol. 2009 Oct;124(4):801-8. doi: 10.1016/j.jaci.2009.07.017. Epub 2009 Sep 19.

PMID:
19767078
[PubMed - indexed for MEDLINE]
18.

Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.

Riedl MA, Bernstein JA, Li H, Reshef A, Lumry W, Moldovan D, Farkas H, Levy R, Baker J, Hardiman Y, Totoritis MC, Relan A, Cicardi M; Study 1310 Investigators.

Ann Allergy Asthma Immunol. 2014 Feb;112(2):163-169.e1. doi: 10.1016/j.anai.2013.12.004. Epub 2014 Jan 7.

PMID:
24468257
[PubMed - indexed for MEDLINE]
19.

Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.

Hofstra JJ, Kleine Budde I, van Twuyver E, Choi G, Levi M, Leebeek FW, de Monchy JG, Ypma PF, Keizer RJ, Huitema AD, Strengers PF.

Clin Immunol. 2012 Mar;142(3):280-90. doi: 10.1016/j.clim.2011.11.005. Epub 2011 Nov 16.

PMID:
22197071
[PubMed - indexed for MEDLINE]
20.

Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety.

Lunn M, Santos C, Craig T.

J Blood Med. 2010;1:163-70. doi: 10.2147/JBM.S9576. Epub 2010 Aug 24.

PMID:
22282695
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk